
Researchers from Mount Sinai published a study in Science Advances that determined the crystal structure of an upstream enzyme involved in glutaric aciduria type 1 (GA1), a rare genetic neuro-metabolic disease. The disease results from GCDH gene deficiencies that cause toxic glutaric acid to build up in the brain.
The study could help drugmakers develop small-molecule inhibitors targeting this enzyme.
This is a biomedical research development with no direct link to feed grains, oilseeds, or animal-feed commodity supply, demand, or prices. It has no plausible effect on feed markets.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.